Skip to content

Drug interactions

Isocarboxazid + Metformin-repaglinide

Severity: Moderate

Isocarboxazid and Metformin-repaglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nonselective MAO inhibitors such as isocarboxazid can lower blood glucose and may enhance the hypoglycemic effect of antidiabetic drugs. Hypoglycemia may be more frequent or pronounced with the repaglinide component and metformin.

What this interaction means in plain words

Isocarboxazid and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Isocarboxazid belongs to Central Nervous System; Metformin-repaglinide belongs to Endocrine.

Evidence level: Low

Why it happens

MAO inhibitors may enhance insulin secretion and sensitivity, producing additive glucose lowering; the exact mechanism is not fully established.

What to do

Monitor blood glucose when starting or stopping isocarboxazid and reduce antidiabetic doses if hypoglycemia occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Isocarboxazid and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Isocarboxazid with Metformin-repaglinide?

MediHelp rates the interaction as moderate. Isocarboxazid and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nonselective MAO inhibitors such as isocarboxazid can lower blood glucose and may enhance the hypoglycemic effect of antidiabetic drugs. Hypoglycemia may be more frequent or pronounced with the repaglinide component and metformin.

How serious is the interaction between Isocarboxazid and Metformin-repaglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or stopping isocarboxazid and reduce antidiabetic doses if hypoglycemia occurs.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in